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Dictyophora indusiata (Vent. ex Pers.) Fish Phallaceae (Chinese name Zhu-S¯ un, the bamboo fungi) has been used as a medicinal
mushroom to treat many inﬂammatory, gastric and neural diseases since 618AD in China. We hypothesize that the soluble
polysaccharides (SP) present in D. indusiata and their monosaccharide proﬁles can act as an important role aﬀecting the
antioxidative capability, which in turn would inﬂuence the biological activity involving anti-inﬂammatory, immune enhancing
and anticancer. We obtained six SP fractions and designated them as D1, a galactoglucan; D2, a galactan; D3, the isoelectrically
precipitated riboglucan from 2% NaOH; D4, a myoinositol;D5 and D6, the mannogalactans. The total SP accounted for 37.44%
w/w, their molecular weight (MW) ranged within 801–4656kDa. D3, having the smallest MW 801kDa, exhibited the most
potent scavenging eﬀect against the α,α-diphenyl-β-picrylhydrazyl, •OH−,a n d•O2
− radicals, yielding IC50 values 0.11, 1.02 and
0.64mgmL−1, respectively. Thus we haveconﬁrmed our hypothesis that the bioactivity of D. indusiata is related in majority, if not
entirely, to its soluble polysaccharide type regarding the MW and monosaccharide proﬁles.
1.Introduction
Dictyophora indusiata (Vent. Ex Pers.) Fish Phallaceae (Chi-
nese name Zhu S¯ un, meaning the bamboo mushroom), syn-
onymouslycalledPhallus indusiatus, isfrequentlyusedunder
the name Veiled lady mushroom (Figure 1). The folkloric
consumption of D. indusiata in the ancient China began
around 618AD, which pointed mainly to the nutritional
bioactivities, likebeneﬁtsto eyesand tonicstocardiovascular
systems; and partially to the medicinal eﬀect like mental
tranquilization, antitumor, and tonics, and so forth, [1–4]. It
consists of seven essential amino acids, 12 precious metallic
ions and rather high content of vitamin E [5, 6], β-carotene,
thiamine, riboﬂavin, nicotinic acid, l-ascorbic acid, calcium
and phosphate [7, 8].
A review by Lindequist indicted that many edible mush-
rooms exhibit a broad spectrum of bioactivities that are
beneﬁcially acting as a complementary alternative medicine
(CAM) [9]. As often cited, the therapeutic eﬃcacy of mush-
rooms includes antibacterial, antifungal, anti-multiresistant
bacterial, antiviral, immunomodulating, antitumor or anti-
tumor adjuvant, cytostatic, immunosuppressive and anti-
allergic,antioxidativeandanti-inﬂammatory, antiatheroscle-
rogenic, hypoglycemic, hepatoprotective, and neurotrophic
functions [9].
The mannan (molecular weight (MW) 620kDa) present
in D. indusiata exhibited potent anticancer bioactivity [10].
Hara et al. isolated two soluble glucans, characteristi-
cally having β − 1 →6b r a n c h e sl i n k e dt oβ-(1→3)-d-
glucosan main frames [11, 12] and exhibiting potent anti-
inﬂammatory [11, 13]a sw e l la sa n t i c a n c e ra c t i v i t y[ 14].
Conversely, Namba et al. and Kodama et al. successively
found in Grifola frondosa (maitake) the antitumor and NK
cells activating polysaccharides that possessed 1→6m a i n2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Fruiting bodies (a) and fungal mycelia (b) of D. indusiata (Vent. Ex Pers.) Fish Phallaceae.
frame of glucan with 1→3 branching side chains (Namba
et al., 1987; Kodama et al., 2003) [15, 16].
Later, Hara et al. identiﬁed a new glucan (MW 510kDa)
[17]a n dan e w( 1 →3)-α-d-mannan [18]. Lin isolated a
polysaccharide (Di-S2P) with a homologous MW 870 kDa
consisting of monosaccharide d-glucose:d-galactose:d-
mannose:xylose in a molar ratio 1.62:1.87:100:0.93 [19].
Morerecently,Wang etal.isolated a water-solubletriple heli-
cal glucan (PD3) having MW 510kDa [20]. These polysac-
charides eﬀectively induced cell mitosis by upregulating
colony forming stimulating factor [21]. Wei indicated that
D. indusiata is an alkaline food in nature, which neutralizes
the acidosis in the mid-aged and the senescent [22], good for
the hypertensive, hypercholesterolemia and hyperlipidemia.
It reduced levels of serum TG, TC and LDL-C, and raised
HDL-C [23]. The Miaw people (a clan of China) use it to
treat injuries and pains, cough, dysentery, enteritis, leukemia
and the feeble [22]. The polysaccharides contained in D.
indusiata has revealed to be eﬀective as anti-tumor, anti-
agglutinating, anti-inﬂammatory, immune-enhancer, and
anti-hyperglycemic. Furthermore, the short skirt Zhu Sun is
a good superoxide anion scavenger; it protects the cellular
membrane lipoproteins from peroxidation, a mechanism
interpreting the anti-cancer and immune-enhancing eﬀect
[22]. Clinically, D. indusiata i so f t e np r e s c r i b e di nC h i n e s e
clinical medicine to treat laryngitis, leucorrhea, fever and
oligourea, diarrhea, hypertension, cough, and hyperlipi-
demia, and more recently in the complimentary anticancer
therapy [13, 21]. Extract of D. indusia had showed strong
antimicrobial eﬀects on bacteria but weak on microzymes
and molds [24]. The radiation protective eﬀect of D.
indusiata was studied by Guo et al. [25]. The thymus and
pancreatic index, CD4+, CD16, CD57 and interleukin 2
were all improved, while CD8+ was decreased [25]. Ke
and Lin obtained a glycoprotein DIGP-2, having the molar
ratio d-galactose:d-glucose:d-mannose = 0.78:2.12:1.00,
which was shown to inhibit 36.2% of Sarcoma 180 cell-
line viability [26]. In addition, Kawagishi et al. and Lee et
al., separately identiﬁed a total of ﬁve neurogrowth factors
[27,28].Ishiyama etal.discoveredﬁvemonoterpenealcohols
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Figure 2 :T h es c h e m es h o w i n gt h eh y p o t h e s i st ob ec o n -
ﬁrmed by the experiment. The extract of D. indusiata exhibits
potent hypolipidemic (i), anti-bacterial (ii), anti-agglutination
(iii), immune-ehancing (iv), anticancer (v), anti-inﬂammatory
(vi) and antioxidative (vii) bioactivities. We hypothesize that the
bioactivities (iv)–(vi) are relevantly aﬀected by the antioxidative
capability, which in turn would be closely related with the soluble
polysaccharides present in D. indusiata and its monosaccharide
proﬁles.
[29].Sharma etal.discoveredthe anti-tyrosinase component
5-(hydroxymethyl)-2-furfural (HMF), a noncompetitive
inhibitor for the oxidation of l-3,4-dihydroxyphenylalanine
(l-DOPA)[30].Mauetal.studieditsantioxidative capability
[31]. Moreover, the extract of Dictyophora was shown to be
eﬀective antimutagenics [32].
Asiswellknown,theantioxidativecapabilitymayberele-
vantly related with its immune-enhacing, anti-inﬂammatory
and anticancer bioactivities. We hypothesize that the SP
presentinD. indusiata andtheirmonosaccharideproﬁlescanEvidence-Based Complementary and Alternative Medicine 3
actasan important role aﬀectingtheantioxidativecapability,
which in turn would inﬂuence the biological activity as
mentioned (Figure 2).
2.Methods
2.1. Chemicals. H2O2 (1mM) and KO2 (as source of 1mM
•O2
−) were products of the Sigma-Aldrich Chemical Co.
(Milwaukee, WI, USA). Standard dextrans and DPPH (α,α-
diphenyl-β-picrylhydrazyl) radical methanolic DMSO solu-
tion (0.5mM) were manufactured by the Sigma Aldrich
Co. (St. Louis, MO, USA). 2-[6-(4 -Amino) phenoxy-3H-
xanthen-3-on-9-yl] benzoic acid (APF) was provided by the
Daiichi Pure Chemicals (Tokyo, Japan).
2.2. Protein Bioassay Kit. BCAprotein assay kit (#23227)was
a product of Pierce Rockford Co. (IL, USA).
2.3. Source of D. Indusiata (Vent. ex Pers.) Fish Phallaceae.
Desiccated fruiting bodies of D. indusiata (Vent. ex Pers.)
Fish were purchased directly from the local supplier at
Ningdeh Hsien of Fujian Province of China. A voucher was
attached as a supplement to the journal editorship.
2.4. Proximate Compositional Analysis. The proximate anal-
ysis was performed according to the methods described in
AOAC [33].
2.5. Fractionation of Soluble Polysaccharides. The fractiona-
tion of diﬀerent SP from the fruiting bodies was performed
according to the ﬂowchart shown in Figure 3 [34].
2.5.1. The Soluble Polysaccharide Fraction D1. Brieﬂy, des-
iccated fruiting bodies of D. indusiata (100g) (DS) was
extracted three times while avoiding direct sunlight by
reﬂuxingwith 2000mL ofdoubledistilledwaterat90◦Cwith
constant stirring at 400×g for 2h. On cooling, the solution
was centrifuged at 10000×g for 30min. The supernatant
(S1) was collected. The extraction was repeated three times.
The residue (R1) was kept for further treatment. The super-
natants were combined and acidiﬁed with 1N HCl to pH 4.
In case that the precipitation should occur instantaneously,
centrifuge the solution immediately at 10000×gt or e m o v e
the ﬁrst precipitate. Otherwise, to the solution (S2) a 3-
fold volume of ethanol was added, stirred for 30min, left
to stand at ambient temperature for 1h and centrifuged at
10000×g for 30min. The precipitate (ppt-1) occurred in
solvent ethanol/hot water (3:1) was collected, dialyzed at
4◦C for 3 days, lyophilized and weighed (SP D1) (Figure 2).
2.5.2. The Soluble Polysaccharide Fraction D2. To the residue
(R1) 2000mL of 0.04N HCl were added and mixed well.
The mixture was reﬂuxed while avoiding direct light sunlight
at 80
◦C for 2h. The extraction was repeated three times,
combined,and centrifuged at 10000×g for30minto collect
the precipitate (R2).To the supernatant (S4)a 3-fold volume
of ethanol was added, stirred at room temperature, left
to stand for 1h and centrifuged at 10000×gf o r3 0 m i n
to collect the precipitate (ppt-2). The supernatant (S5)
was discarded. The ppt-2 obtained in the mixed solvent
ethanol/0.04N HCl (3:1) was dialyzed at 4◦C, lyophilized
and weighed to obtain the SP D2 (Figure 2).
2.5.3. The Soluble Polysaccharide Fraction D5. To the residue
R2 2000mL of 2% NaOH were added and mixed well. The
mixture was reﬂuxed while avoiding direct sunlight at 80
◦C
for 2h. The extraction was repeated for three times. The
extracts were combined, cooled, and subjected to centrifu-
gation at 10000×g for 30min. The precipitate (ppt-5) was
discarded (Figure 2). To the supernatant (S10) 1N HCl was
added to adjust the pH to 4.0. The acidiﬁed solution was left
to stand at ambient temperature for 1h. The mixture was
centrifuged at 10000×g to collect the isoelectric precipitate
from 10% KOH (ppt-6), which was dialyzed, lyophilized and
weighed to obtain the SP D5 (Figure 2).
2.5.4. The Soluble Polysaccharide Fraction D6. To the super-
natant (S11) 3-fold volume of ethanol was added. The
solution was stirred at ambient temperature for 30min
and centrifuged at 10000×g. The precipitate obtained in
the ethanol/10% KOH (3:1) mixed solvent was collected,
lyophilized and weighed to obtain the SP D6 (Figure 2).
2.5.5. The Soluble Polysaccharide Fraction D3. Alternatively,
to the supernatant S6 2000mL of NaOH was added and
reﬂuxed at 80
◦C for 2h. The mixture was left to stand at
ambient temperature for 1h and centrifuged at 10000×g
to obtain the supernatant (S7). The precipitate (ppt-3)
was discarded (Figure 2). An amount of 1N HCl was
used to adjust the pH value of S7 to 4.0. The acidiﬁed
solution was left to stand at ambient temperature for 1h
and centrifuged at 10000×gf o r3 0 m i n .T h ep r e c i p i t a t e
occurred by the isoelectric precipitation from 2% NaOH
(ppt-4) was collected, dialyzed, lyophilized and weighed to
obtain the SP D3 (Figure 2).
2.5.6. The Soluble Polysaccharide Fraction D4. To the super-
natant (S8) a 3-fold volume of ethanol was added and
stirred for30min. The solutionwascentrifuged at 10000×g
for 30min to obtain the precipitate. The supernatant (S9)
was discarded (Figure 2). The precipitate collected from
the ethanol/2% NaOH (3:1) was dialyzed, lyophilized and
weighed to obtain the SP D4 (Figure 2).
2.6. Determination of the Carbohydrate Content. The car-
bohydrate content in each fraction was determined by the
phenol-H2SO4 method [35].
2.7. Determination of the Protein Content. The protein
contentineachfraction wasdeterminedbythebicinchoninic
acid (BCA) protein assay kit (#23227, Pierce Rockford, IL,
USA) following the manufacturer’s instructions.
2.8.GPCSieving. To20mgofeachfraction(D1–D6)1mLof
10% NaOH and suﬃcient double distilled water were added4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Flow chart showingthe extraction protocol for isolationof soluble polysaccharides from the fruiting bodies of D. indusiata (Vent.
Ex Pers.) Fish Phallaceae. DS: sample of desiccated D. indusiata fruiting body.
to make a ﬁnal volume of 5mL. The mixture was thoroughly
agitated to facilitate the dissolution and centrifuged at
2500×g for 10min to remove the insoluble precipitate.
The supernatant was decanted, each 3mL of which was
eluted with 0.05N NaOH solution containing 0.02% NaN3
at a ﬂow rate 0.5mLmin−1 on the Sephadex G-100 column
(internal diameter (i.d.) × l = 2.5 × 100cm). The fraction
collector(ISCORetriever500,Isco.,Lincoln,NE)wasusedto
collecttheeluents,6mLpertube.Thecollectionwasstopped
at the 100th tube. The calibration curve was established
using the authentic dextrans having molecular masses 8.8,
40, 500, 2000 and 5000–40000kDa (Sigma, St Louis, MO,
USA), respectively. The molecular mass distribution and the
averagemolecularmasswascalculatedagainst thislinearcor-
relation between the logarithm of each standard molecular
mass and the ratio the eluted to the void volume [36].
2.9. Analysis for Ratio Carbohydrate to Peptide Moiety.
Diﬀerent SP (D1–D6) was subjected to the Sephadex G-100
column separation. The Dubois’ phenol-sulfuric acid colori-
metric method [30] was followed to determine the carbohy-
drate content. Brieﬂy, to each milliliter of the polysaccharide
fraction 1mL of phenol reagent (5%) and 5mL of sulfuric
acid were added. On cooling tothe ambient temperature, the
optical density was read at 490nm. Alternatively, Coconnier
et al. [37] was followed for the determination of peptido-
moiety. The absorbance at 280nm was taken straightfor-
wardly for thesix SPfractions (D1–D6)obtained from GPC.
2.10. Acid Hydrolysis. Three grams of each sample SP were
accurately weighed and transferred separately into a 2mL
reaction vessel, to which 2mL of 6M HCl was added. The
dissolved oxygen was purged oﬀ by nitrogen blowing forEvidence-Based Complementary and Alternative Medicine 5
10min. The vessel was sealed, placed in the derivatization
reactor, and heated at 110◦C for 24h until the peptide
moiety was completely hydrolyzed. The hydrolyzed product
was lyophilized. The desiccated product was re-dissolved
in 0.3mL of 0.01M HCl to obtain the sample amino-acid
mixture (AM).
2.11. Derivatization of Amino Acid and Extraction. An
amount of 0.3mL of authentic and AM (0.6mL) solutions
were respectively placed into a 3-mL reaction vessels, to
which the internal standard solution of norleucine (0.01mL,
10mgmL−1) was added. When vigorously agitated, 0.1mL
of ethyl chloroformate and 1mL of alcohol-pyridine were
added and mixed thoroughly. To the mixture 2mL of chlo-
roform were added. When mixed well for 1min to facilitate
the derivatization and the extraction, water (0.7mL) was
added, shaken well, and left to stand for 5min to facilitate
phase separation. The supernatant was discarded. The lower
layer (i.e., the chloroform layer) was transferred into a new
tube and dehydrated with 0.1g of anhydrous sodium sulfate.
The dehydrated chloroform extract was transferred into the
sample vessel and analyzed by GC/MS.
2.12. GC/MS Analysis. The GC/MS chromatography (Angi-
lent 6890, Wilmington, DE, USA) installed with an FID
detector and a column HP-5MS was used for GC/MS
analysis. The HP-5MS column had a length l = 30m with
i.d. = 0.25mm and ﬁlm thickness = 0.25μm. The ﬂow rate
of carrier nitrogen gas was operated at 0.8mLmin−1.T h e
temperature of the detector FID and the injection port was
held at 305 and 300◦C, respectively. The elution temperature
was programmed initially at 50
◦Cf o r1m i n ,t h e nr a i s e da t
an elevation rate 10
◦Cmin −1 to 300
◦C and held at which for
6.5min.
2.13. Assay for Antioxidative Capability—Preparation of SP
Solutions. To 250mg of SP (D1–D6) samples, 1mL of 10%
NaOH and suﬃcient double distilled water were added to
make a ﬁnal volume of 5mL. The mixture was thoroughly
agitated to facilitate the dissolution and centrifuged at
2500×g for 10min to remove the insoluble precipitate.
The supernatant was collected (SP stock solution) for the
following assays.
2.13.1. Scavenging Capability for DPPH Radicals. Method
of Blois [38], later modiﬁed by Shimada et al. [39], was
followed for assay of the DPPH radicals. Brieﬂy, to 1mL
of DPPH (methanolic DMSO solution, 0.5mM, Sigma-
Aldrich Co., MO, USA) an appropriate amount of each SP
stock solution (20–100μL) or the standard was added. The
mixture was thoroughly agitated and left to stand for 30min.
The absorbance was read at 517nm using the BioMate
5 spectrophotometer (Thermo Electron Corporation, San
Jose,CA,USA).DHAwasusedasthereferencestandard.The
percent DPPH radical scavenging activity was calculated as
directed [38, 39].
2.13.2. Scavenging Capability for Hydroxyl- and Superoxide
Anion Radicals. The modiﬁed method of Adom and Liu
Table 1: Proximate composition of the fruiting bodies of D.
indusiata (Vent. Ex Pers.) Fish Phallaceaea.
Composition Content (% w/w)
Moisture 10.55 ± 0.02
Crude ash 6.58 ± 0.01
Crude fat 1.26 ± 0.02
Crude ﬁber 28.65 ± 0.05
Crude protein 6.07 ± 0.03
Carbohydrate 46.89 ± 0.04
aE a c hv a l u ei se x p r e s s e da sm e a n± SD (n = 3).
[40]m o d i ﬁ e db yN a k a j i m a[ 41] was used for the assay of
antioxidant-capacity against the intracellular reactive oxygen
species (ROS, including H2O2, •O2
− and •HO). Brieﬂy,
cells were seeded at a density of 2 × 103 cells per well
onto a 96-well plate and incubated at 37
◦Cf o r2 4 hi n
the humidiﬁed atmosphere containing 5% CO2.E a c ht i m e
the cell-culture medium was replaced fresh before any
treatment with the soluble polysaccharide fraction of D.
indusiata or the vehicle (DMEM containing 1% FBS) alone.
On treatment for 1h, 10μM of 5-(and-6)-chloromethyl-
2 ,7 -dichlorodihydroﬂuorescein diacetate (CM-H2DCFDA)
(Molecular Probes, Eugene, OR, USA) was added to serve
the radical probe. The incubation was further continued for
20minat37◦Candthemediumwasreplacedfresh toremove
excess probe. In principle, CM-H2DCFDA (nonreactive
to ROS) will be converted to dichlorodihydroﬂuorescein
(DCFH) (reactive to ROS) by the intracellular enzyme
esterase during incubation. The H2O2 or •O2
− will then
oxidize the intracellular non-ﬂuorescent DCFH to produce
ﬂuorescence active dichloroﬂuorescein (DCF). To generate
H2O2 or •O2
−,1m MH 2O2 (Wako Pure, Osaka, Japan) or
1mM K O 2 (Aldrich Chemical Co., Milwaukee, WI, USA)
was added. While ROS was still continuously persisting,
the ﬂuorescence was measured at 485/535nm as the excita-
tion/emission wavelengths using the Skan It RE (Varioskan
Flash 2.4, Thermo Fisher Scientiﬁc, Waltham, MA, USA).
Alternatively, for detection of the hydroxyl free radical •HO,
2-[6-(4 -amino) phenoxy-3H-xanthen-3-on-9-yl] benzoic
acid (APF) (Daiichi Pure Chemicals, Tokyo, Japan) was
used. Brieﬂy, cells were incubated for 20 min at 37
◦C
in Hanks/Hepes buﬀer solution containing APF (10μM).
H2O2 was added to initiate the Fenton reaction. Finally
iron (II) perchlorate hexahydrate (Wako Pure Chemicals,
Osaka, Japan) was added. The ﬂuorescence was measured
at the excitation/emission wavelength 490/515nm. The total
intensity was calculated by integrating the scanned area
under the DCFH.
2.14. Statistical Analysis. Data obtained in the same group
were analyzed by Student’s t-test with computer statistical
software SPSS 10.0 (SPSS, Chicago, IL). Statistical analysis
system software was used to analyze the variances. Duncan’s
multiple range tests were used to test their signiﬁcances of
diﬀerence between paired means. Signiﬁcance of diﬀerence
was judged by a conﬁdence level of P<. 05.6 Evidence-Based Complementary and Alternative Medicine
Table 2: Percent yield, mean molecular weight, and the content of carbohydrate and protein of the soluble polysaccharides obtained from
the fruiting bodies of D. indusiataa.
Extract Yield (% w/w) Carbohydrate (% w/w) Protein (% w/w) Mean MW (kDa)b
D1 7.4 ± 0.8 58.3 ± 3.5 19.5 ± 2.1 4656 ± 427
D2 9.3 ± 1.0 98.8 ± 5.6 1.1 ± 0.1 2118 ± 216
D3 2.3 ± 0.1 27.2 ± 1.5 72.6 ± 4.2 801 ± 82
D4 11.8 ± 1.1 90.7 ± 4.7 8.9 ± 1.5 2919 ± 258
D5 0.1 ± 0.0 27.4 ± 1.6 55.1 ± 2.8 Unanalyzedc
D6 6.6 ± 0.4 42.3 ± 2.4 8.6 ± 1.4 1375 ± 163
Total 37.5 — — —
aWeight-based percentage of soluble polysaccharidesin 100g of lyophilized fruiting body powder of D. indusiata. D1: the 3-fold ethanol precipitate from hot
water extracts. D2: the 3-fold ethanol precipitate from 0.04N HCl extracts. D3: the isoelectric precipitate from 2% NaOH extracts. D4: the 3-fold ethanol
precipitate from 2% NaOH extracts. D5: the isoelectric precipitate from 10% KOH extracts; and D6: the 3-fold ethanol precipitate from 10% KOH extracts.
Carbohydrate content (% w/w) was measured by the phenol-H2SO4 method. Protein content (% w/w) was determined by Bradford protein assay.
bMean molecular weight.
cUnanalyzed due to insuﬃcient quantityof sample.
Table 3: Pattern of soluble polysaccharides isolated from the fruiting bodies of D. indusiata (Vent. Ex Pers.) Fish Phallaceaea.
Sugar (mole%) D1 D2 D3 D4 D5 D6
Rhamnose 1.0 ± 0.1d 0.2 ± 0.0d 13.6 ± 0.1a 0.3 ± 0.0d 1.8 ± 0.1b 1.1 ± 0.0c
Fucose 1.3 ± 0.1c 0.3 ± 0.0d 3.7 ± 0.0a 0.3 ± 0.0d 2.0 ± 0.1b 2.3 ± 0.0b
Ribose 1.4 ± 0.1b 0.1 ± 0.0d 24.3 ± 0.1a 0.4 ± 0.0c ud ud
Arabinose 1.6 ± 0.2b 0.7 ± 0.1c 3.3 ± 0.1a 0.8 ± 0.1c ud 1.8 ± 0.0b
Xylose ud 1.4 ± 0 . 1 u du du du d
Allose ud ud ud 0.3 ± 0.0b ud 2.2 ± 0.0a
Talose ud ud ud ud ud ud
Mannose 5.9 ± 0.3b 0.4 ± 0.1d 6.9 ± 0.1b 2.4 ± 0.2e 24.7 ± 0.3a 28.0 ± 0.2a
Galactose 14.2 ± 0.3c 19.7 ± 0.3b 2.9 ± 0.0d 2.0 ± 0.1e 66.2 ± 0.5a 62.0 ± 0.3a
Glucose 6.9 ± 0.3b 2.0 ± 0.1d 35.9 ± 0.2a 1.1 ± 0.0e ud 2.7 ± 0.1c
Myo-inositol 67.9 ± 0.3c 76.5 ± 0.3b 9.4 ± 0.1d 92.5 ± 0.4a 5.3 ± 0.2e ud
ud: undetected. Diﬀerent superscripts in each column denote signiﬁcant diﬀerence (P<. 05) between fractions D1–D6.
aWeight-basedpercentage of polysaccharidesextracted from 100g of lyophilizedfruiting body powder of D. indusiata. D1: the 3-foldethanol precipitatefrom
hot water extracts.D2: the 3-fold ethanol precipitate from 0.04N HCl extracts.D3: the isoelectric precipitate from 2% NaOH extracts.D4: the 3-fold ethanol
precipitate from 2% NaOH extracts. D5: the isoelectric precipitate from 10% KOH extracts; and D6: the 3-fold ethanol precipitate from 10% KOH extracts.
Carbohydrate content (% w/w) was measured by the phenol-H2SO4 method. Protein content (% w/w) was determined by Bradford protein assay.
3.Results
3.1. Proximate Composition. The fruiting bodies of D. indu-
siata contained huge amount of carbohydrates and crude
ﬁbers reaching 46.89 and 28.65%, respectively. In contrast, it
had only 6.07% of crude protein (Table 1). The SP yielded
37.5%, accounting for ∼80% (37.50/46.89 ≈ 0.8) of the
total polysaccharides. The order of percentage yield (%w/w)
was D4 (11.8) > D2 (9.3) > D1 (7.4) > D6 (6.6) > D3
(2.3) (calculated from Tables 1 and 2). Fraction D2 had the
smallest protein to carbohydrate ratio (0.011), the order in
increasing trend was: D4 (0.098) < D6 (0.203) < D1 (0.335)
< D5 (2.011) < D3 (2.670). The mean MW ranged within
801–4656kDa (Table 2). Among which fraction D3 had the
smallest MW 801kDa, D6 (MW 1375kDa) the next, while
D1 was the largest (4656kDa) (Table 2).
3.2. Monosaccharide Composition. Ten kinds of monosac-
charides were found in the SP of D. indusiata.O b e y i n g
the conventional naming rule, fraction D1 was designated
glucogalactan; D3, the riboglucan, and both D5 and D6, the
mannogalactans. Interestingly, huge amount of myo-inositol
was simultaneously found in fractions D4, D2), and D1
(Table 3).
3.3. Antioxidative Capability. Fraction D3 at 1mgmL−1 ex-
hibited the most potent DPPH radical scavenging capability,
D6 and D2 were the next, reaching 72, 60 and 47%,
respectively. The order in strength was D3 > D6 > D2 >
D4 > D1 (Figure 4). Regarding the scavenge for the hydroxyl
radicals, fraction D3 also showed the most prominent
bioactivity (reaching 50%) with the order D3 > D2 > D6
> D4 > D1 (Figure 5). Conversely, in scavenging superoxide
anion radicals, the order changed to D4 (46%) ≈ D1 (44%)
≈ D2 (43%) > D3 (28%) > D6 (3%) (Figure 6). To further
measure thecrucialsensitivity, valuesofIC50 were compared.
As seen, values of IC50 ranged within 0.11–3.93mgmL−1
for DPPH, among which D3 was the most potent, and in
contrast D1almost hadnoeﬀecttowardDPPHand •OHfree
radicals (Table 4). To summarize, fraction D3 possessing theEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Scavenging capability of diﬀerent polysaccharides frac-
tionated from the fruiting bodies of D. indusiata for DPPH
radicals. The dose ranged within 0–5.0mgmL−11 (upper). Values
are expressed in means ± SD (n = 3).
Table 4: The IC50 values of diﬀerent soluble polysaccharide
fractions obtained from the fruiting bodies of D. indusiata for
scavenging the DPPH-, hydroxyl- and superoxide anion radicalsa.
Polysaccharide
fractiona
IC50,DPPH
(mgmL−1)
IC50,•OH
(mgmL−1)
IC50,superoxide
(mgmL−1)
D1 ud ud 1.76
D2 3.93 4.39 ud
D3 0.11 1.02 0.64
D4 2.06 8.99 1.63
D6 0.75 5.63 4.79
ud: undetected.
aWeight-based percentage of polysaccharides extracted from 100g of
lyophilized fruiting body powder of D. indusiata. D1: the 3-fold ethanol
precipitate from hot water extracts. D2: the 3-fold ethanol precipitate
from 0.04N HCl extracts. D3: the isoelectric precipitate from 2% NaOH
extracts.D4: the 3-fold ethanol precipitate from 2% NaOH extracts.D5: the
isoelectric precipitate from 10% KOH extracts; and D6: the 3-fold ethanol
precipitate from 10% KOH extracts. Carbohydrate content (% w/w) was
measured by the phenol-H2SO4 method. Protein content (% w/w) was
determined by Bradford protein assay.
smallest MW (801kDa) exhibited the most eﬀective overall
antioxidative potency.
4.Discussion
ThefruitingbodiesofD. indusiata containedhugeamountof
carbohydrates(46.89%).Inparallel,itscrudeproteincontent
was only 6.07%, implicating the possible peptidoglycan
structure underling the main medicinal eﬀect. Data revealed
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Figure 5: Scavenging capability of diﬀerent polysaccharides frac-
tionated from the fruiting bodies of D. indusiata for hydroxyl
radicals.The doserangedwithin 0–5.0mgmL−1 (upper). Valuesare
expressed in means ± SD (n = 3). Values are expressed in means ±
SD (n = 3).
that only fractions D1, D2, D4 and D6 were peptidoglycan
in nature. As a contrast, fractions D3 and D5 were typically
characteristic of glycoproteins. Moreover, the high total SP
content(37.44%)may alsoimplicateanalternatetherapeutic
use. By insight of monosaccharide proﬁle, fraction D1 was
designated a glucogalactan; D3, a riboglucan; D5 and D6,
mannogalactans. Fraction D4, having myo-inositol content
92.5%, almost was approaching the pure myo-inositol. Lin
puriﬁed a polysaccharide xylose-containing Di-S2P from D.
indusiata fruiting bodies. Di-S2P had MW 870kDa [19],
however xylose was undetected in D3. Worth noting, D4 and
D6 uniquely contained allose (Table 3).
Aswellknown,inositolepimerasegovernstheconversion
of myo-inositol to chiro-inositol [42–44], an insulin depen-
dent process related with immunological activity. Myo-
inositol is an essential nutrient required for keratinocytes
growth [45, 46]. The actual role of such an unusually
high content of myo-inositol in D. indusiata acting as
immunomodulatorremains tofurther investigation.D3pos-
sessed the most potent DPPH radical scavenging capability
prevailing over the mannogalactan (D6), implicating the
complicate phytochemical-therapeutics relationship [47].
As well cited, the binding of glucans having (1→3)-β-d-
glucosan main frame with β-d-(1→6) branches onto the
cell surface of cytotoxic macrophages, helper T and NK
cells will trigger immunopotentiation [47, 48]. The degree
of branching (DB) between 0.20 and 0.33 and the triple
helical structures are important for immunopotentiating
[47]. Conversely, some insoluble aggregates also had been
reported to be more stimulatory than the soluble polymers8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Scavenging capability of diﬀerent polysaccharides frac-
tionated from the fruiting bodies of D. indusiata for superoxide
anion radicals. The dose ranged within 0–5.0mgmL−1 (upper).
Values are expressed in means ± SD (n = 3).
[47]. A water-insoluble, alkali-soluble extracellular glucan
(CO-1) (average MW ∼632 kDa) isolated from Cordyceps
ophioglossoides was shown to inhibit the Sarcoma 180 tumor
[48].
To conclude, the fruiting bodies of D. indusiata contain
huge amount of SP (37.5%) that exhibits MW ranging
within 801–4656kDa. Among which, the fraction D3 (the
isoelectrically precipitated riboglucan from 2% NaOH) has
the smallest MW 801 and is the most potent SP regarding
the antioxidative capability. Furthermore, the huge amount
of myo-inositol present can be relevantly associated with its
additional immunobioactivity. Thus, we have conﬁrmed our
hypothesis that the bioactivity of D. indusiata is related in
majority, if not entirely, to its soluble polysaccharides.
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